Avin Maroof

ORCID: 0000-0002-6554-5314
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Spondyloarthritis Studies and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Macrophage Migration Inhibitory Factor
  • Health Systems, Economic Evaluations, Quality of Life
  • Musculoskeletal pain and rehabilitation
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Inflammatory Bowel Disease
  • Peripheral Neuropathies and Disorders
  • Adipose Tissue and Metabolism
  • Pregnancy and Medication Impact
  • Systemic Lupus Erythematosus Research
  • Cytokine Signaling Pathways and Interactions
  • Pregnancy-related medical research
  • Biosimilars and Bioanalytical Methods
  • T-cell and B-cell Immunology
  • Long-Term Effects of COVID-19
  • Healthcare Systems and Reforms
  • Pharmaceutical Economics and Policy
  • Immune Cell Function and Interaction
  • Intramuscular injections and effects
  • COVID-19 Clinical Research Studies
  • Dermatological and COVID-19 studies
  • SARS-CoV-2 and COVID-19 Research

University of Kurdistan Hewler
2021-2025

Baghdad Medical City
2019-2024

Hawler Medical University
2024

University of Kurdistan
2023

Cihan University-Erbil
2021

Objectives:The main purpose of this study was to determine the frequency COVID-19 vaccine side effects in patients with rheumatic diseases and examine any potential associations medications, disease type, or comorbidities.Methods: A multicentre cross-sectional from rheumatology units different hospitals Iraq carried out between 8 th August 2021 4 2022.Patients were eligible for inclusion if they have a taken one more doses vaccine.Results: total 661 (57.8% female, mean age 46.51± 12.97...

10.31138/mjr.140223.sof article EN Mediterranean Journal of Rheumatology 2024-03-01

Abstract JAK/STAT signaling pathway plays a significant role in cytokines and growth factors involved the pathogenesis of rheumatoid arthritis (RA). STAT3 is major downstream mediator important pro‐inflammatory Th‐17 cell differentiation playing regulating Th‐17/ Treg balance development autoimmune diseases, especially RA. Studies also have reported inflammatory destructive functions synovial fibroblasts (SFs) STA‐21 small molecule inhibitor that can inhibit activation impairing expression...

10.1111/1756-185x.15032 article EN International Journal of Rheumatic Diseases 2024-01-01

Background: There are scarce data on disease characteristics and severity of coronavirus 2019 (COVID-19) among Iraqi patients with rheumatic diseases (RDs).In this study, we aimed to report the variables associated COVID-19 outcome RDs.Methods: Between October 2020 April 2021, (RDs) were registered from different centres in Iraq.The patient's demographics, rheumatological history, symptoms, severity, management, if any, their progress have been assessed.Binary logistic regression analysis...

10.31482/mmsl.2021.038 article EN Military Medical Science Letters 2021-12-06

<h3>Background</h3> The Psoriatic Arthritis Impact of Disease (PsAID) is a patient-reported questionnaire assessing multiple domains in patients with psoriatic arthritis (PsA), developed under the aegis EULAR, and recommended by OMERACT GRAPPA. To be usable different contexts, translations cross-cultural validations are necessary. Arabic sixth most-spoken language world; however, many outcomes not available Arabic. <h3>Objectives</h3> translate, culturally adapt validate PsAID-12 Arabic, to...

10.1136/annrheumdis-2023-eular.3209 article EN Annals of the Rheumatic Diseases 2023-05-30

<h3>Background:</h3> Bone marrow edema (BME) and structural damage (fat metaplasia, erosions, sclerosis, backfill) on magnetic resonance imaging (MRI) of the sacroiliac joint (SIJ), qualitatively identified as sacroiliitis, are a hallmark axial spondyloarthritis (axSpA). SIJ lesions MRIs postpartum women (PPW), potentially influenced by pregnancy-related mechanical stress, may complicate distinction to axSpA. Additionally, patients with inflammatory bowel diseases (IBD) at an increased risk...

10.1136/annrheumdis-2024-eular.1236 article EN Annals of the Rheumatic Diseases 2024-06-01

Background: Adalimumab is approved for Rheumatoid Arthritis (RA). In 2021, A biosimilar (ABP501;Amgevita®) was licensed in Iraq. The current study aimed to ensure safety and Efficacy of Amgevita RA Patients Methods: Cross sectional Observational Started on 69 Records receiving Amgevita. Data collected from local registry then examined disease activity adverse reactions 9 months follow up. Results: Thirty patients completed the period study: aged (49±14) years; 77.5% females. After 3, 6 up,...

10.47723/2km3dk27 article EN cc-by AL-Kindy College Medical Journal 2024-12-01

<h3>Background</h3> In patients with psoriatic arthritis (PsA), discordance between physicians and when assessing disease activity has been described as frequent, mainly in European North American studies. This may negatively impact treatment adherence shared decision-making processes. Culture beliefs influence patients' perceptions of health. <h3>Objectives</h3> To evaluate the concordance patient- (PGA) physician-global assessment (PhGA) PsA its association demographic characteristics a...

10.1136/annrheumdis-2023-eular.2371 article EN Annals of the Rheumatic Diseases 2023-05-30

ObjectivesThe Psoriatic Arthritis Impact of Disease (PsAID-12) questionnaire is the recommended measure patient-reported impact for psoriatic arthritis (PsA); it was developed in Europe and may not be valid all cultures. The objective to translate, culturally adapt validate PsAID Arabic.Methods PsAID-12 translated into Arabic (double translation, back-translation, cognitive debriefing), then validated through a study conducted 13 Arab countries 2022. Participants were consecutive literate...

10.2139/ssrn.4605650 preprint EN 2023-01-01

Abstract: BACKGROUND: Adalimumab, a tumor necrosis factor-α inhibitor, is an approved treatment for ankylosing spondylitis (AS). In Iraq, biosimilar of adalimumab (ABP 501; Amgevita®) has been licensed prescription since 2021. However, there have no previous studies on its efficacy and safety in Iraqi AS patients. Multiple shown that biosimilars are effective well tolerated, with comparable rates clinical response, adverse events (AEs), immunogenicity to the reference product. OBJECTIVES: To...

10.4103/ajr.ajr_9_23 article EN cc-by-nc-sa Deleted Journal 2023-07-01

<h3>Background</h3> Fibromyalgia (FM) is a chronic idiopathic disease characterized by diffuse pain, fatigue, sleep disturbances, stiffness, anxiety and depression. Compared to healthy subjects. FM patients have significant high ratios of mean platelet volume, Neutrophil-to-lymphocyte, lymphocyte. showed abnormal lipid profile higher levels fasting serum triglyceride cholesterol. <h3>Objectives</h3> This study aimed derive from the circulating inflammatory cells lipoprotein as markers...

10.1136/annrheumdis-2019-eular.2487 article EN Annals of the Rheumatic Diseases 2019-06-01
Coming Soon ...